Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels

作者: Yoshimi Matsumoto , Kohei Hayama , Shouichi Sakakihara , Kunihiko Nishino , Hiroyuki Noji

DOI: 10.1371/JOURNAL.PONE.0018547

关键词: BiochemistryMembrane transport proteinFluorescence microscopeEscherichia coliPolymyxin BChemistryFluorescenceFluoresceinEffluxFluorescence-lifetime imaging microscopyGeneral Biochemistry, Genetics and Molecular BiologyGeneral Agricultural and Biological SciencesGeneral Medicine

摘要: Fluorescein-di-β-d-galactopyranoside (FDG), a fluorogenic compound, is hydrolyzed by β-galactosidase in the cytoplasm of Escherichia coli to produce fluorescent dye, fluorescein. We found that both FDG and fluorescein were substrates efflux pumps, have developed new method evaluate efflux-inhibitory activities E. using microfluidic channel device. used MG1655 wild-type, ΔacrB (ΔB), ΔtolC (ΔC) ΔacrBΔtolC (ΔBC) harboring plasmids carrying mexAB-oprM (pABM) or mexXY-oprM (pXYM) genes Pseudomonas aeruginosa. Two inhibitors, MexB-specific pyridopyrimidine (D13-9001) non-specific Phe-Arg-β-naphthylamide (PAβN) evaluated. The effects inhibitors on pumps observed device under fluorescence microscope. AcrAB-TolC analogous effectively prevented influx wild-type cells, resulting no fluorescence. In contrast, ΔB ΔC easily imported fluorescein, which was exported residual ΔB. Consequently, medium cells ΔBC channels. D13-9001 substantially increased cell number ΔBC/pABM but not ΔBC/pXYM. PAβN all strains, especially pump deletion mutants, caused accumulation disappear ΔC. checkerboard revealed acts synergistically with aztreonam, ciprofloxacin, erythromycin only against MexAB-OprM producer (ΔBC/pABM), synergistically, erythromycin, strains including mutants. results obtained from similar membrane permeabilizer, polymyxin B nonapeptide concentration. clarified specifically inhibited contrast PAβN, appeared be substrate permeabilized membranes coli.

参考文章(45)
M Vaara, Agents that increase the permeability of the outer membrane. Microbiological Research. ,vol. 56, pp. 395- 411 ,(1992) , 10.1128/MR.56.3.395-411.1992
Vladislav V. Mokhonov, Ekaterina I. Mokhonova, Hiroyuki Akama, Taiji Nakae, Role of the membrane fusion protein in the assembly of resistance-nodulation-cell division multidrug efflux pump in Pseudomonas aeruginosa. Biochemical and Biophysical Research Communications. ,vol. 322, pp. 483- 489 ,(2004) , 10.1016/J.BBRC.2004.07.140
Kunihiko Nishino, Yasuko Senda, Akihito Yamaguchi, Kunihiko Nishino, Akihito Yamaguchi, Kunihiko Nishino, Akihito Yamaguchi, The AraC-family regulator GadX enhances multidrug resistance in Escherichia coli by activating expression of mdtEF multidrug efflux genes. Journal of Infection and Chemotherapy. ,vol. 14, pp. 23- 29 ,(2008) , 10.1007/S10156-007-0575-Y
K. Nagano, H. Nikaido, Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 5854- 5858 ,(2009) , 10.1073/PNAS.0901695106
Gaby Sennhauser, Magdalena A. Bukowska, Christophe Briand, Markus G. Grütter, Crystal Structure of the Multidrug Exporter MexB from Pseudomonas aeruginosa Journal of Molecular Biology. ,vol. 389, pp. 134- 145 ,(2009) , 10.1016/J.JMB.2009.04.001
Martti Vaara, New approaches in peptide antibiotics. Current Opinion in Pharmacology. ,vol. 9, pp. 571- 576 ,(2009) , 10.1016/J.COPH.2009.08.002
P Viljanen, M Vaara, Susceptibility of gram-negative bacteria to polymyxin B nonapeptide. Antimicrobial Agents and Chemotherapy. ,vol. 25, pp. 701- 705 ,(1984) , 10.1128/AAC.25.6.701